Status:

COMPLETED

Effect of Low-level Laser Therapy on Salivary Flow, pH and Quality of Life in Irradiated Oropharyngeal Cancer Patients

Lead Sponsor:

Ziauddin University

Conditions:

Xerostomia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

There are multiple treatment modalities for head and neck cancer. They include radiation therapy, chemotherapy and surgery. Radiation therapy aims to control the tumor with minimum damage to adjacent ...

Detailed Description

There are multiple treatment modalities the cancers of the head and neck. The main three major treatment options are surgery, radiation therapy and chemotherapy. Radiation therapy (RT) is used to cont...

Eligibility Criteria

Inclusion

  • Patients with radiation induced persistent xerostomia which will be confirmed clinically and by taking salivary flow rate. Patients which will have salivary flow rate less than 0.1-0.2 ml/min shall be included.
  • Patients treated with therapeutic RT for oropharyngeal cancers 3 to 36 months ago
  • Patients whose age was equal to or more than 18 years irrespective of gender.

Exclusion

  • Patients with other determined causes of xerostomia which have been confirmed. Systemic conditions (specially checking and excluding patients having dehydration,patients with known diseases of salivary glands, salivary glands removal surgery, smoking, diabetes, and autoimmune disorders among such as Sjögren's syndrome and drugs that cause xerostomia.

Key Trial Info

Start Date :

November 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 3 2021

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT04738227

Start Date

November 6 2020

End Date

February 3 2021

Last Update

July 30 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ziauddin University

Karachi, Sindh, Pakistan, 75500

Effect of Low-level Laser Therapy on Salivary Flow, pH and Quality of Life in Irradiated Oropharyngeal Cancer Patients | DecenTrialz